Shanxi C&Y Pharmaceutical Group Co Ltd (300254) — Cash Flow Reinvestment Rate
Shanxi C&Y Pharmaceutical Group Co Ltd (300254) has a Cash Flow Reinvestment Rate of 0.20x as of September 2025, reinvesting CN¥10.37 Million (capex CN¥10.37 Million ) from operating cash flow of CN¥52.93 Million. See Shanxi C&Y Pharmaceutical Group Co Ltd (300254) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shanxi C&Y Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate (2009–2025)
Historical reinvestment intensity for Shanxi C&Y Pharmaceutical Group Co Ltd across 16 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Shanxi C&Y Pharmaceutical Group Co Ltd.
Annual Cash Flow Reinvestment Rate for Shanxi C&Y Pharmaceutical Group Co Ltd (2009–2025)
Year-by-year capital reinvestment analysis for Shanxi C&Y Pharmaceutical Group Co Ltd. See financial agility of Shanxi C&Y Pharmaceutical Group Co Ltd to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.95x | CN¥92.24 Million | CN¥96.77 Million | CN¥34.32 Million | ▼ -73.1% |
| 2024 | 3.55x | CN¥251.51 Million | CN¥70.94 Million | CN¥51.50 Million | ▲ +242.9% |
| 2023 | 1.03x | CN¥39.10 Million | CN¥37.81 Million | CN¥33.92 Million | ▲ +54.9% |
| 2022 | 0.67x | CN¥49.98 Million | CN¥74.88 Million | CN¥26.78 Million | ▲ +52.2% |
| 2021 | 0.44x | CN¥42.50 Million | CN¥96.92 Million | CN¥36.93 Million | ▼ -91.4% |
| 2019 | 5.07x | CN¥353.02 Million | CN¥69.63 Million | CN¥18.54 Million | ▼ -46.5% |
| 2018 | 9.47x | CN¥364.07 Million | CN¥38.44 Million | CN¥29.59 Million | ▲ +172.7% |
| 2017 | 3.47x | CN¥139.29 Million | CN¥40.10 Million | CN¥101.07 Million | ▼ -30.0% |
| 2016 | 4.96x | CN¥206.54 Million | CN¥41.65 Million | CN¥50.78 Million | ▼ -60.7% |
| 2015 | 12.61x | CN¥194.77 Million | CN¥15.44 Million | CN¥35.68 Million | ▲ +2931.1% |
| 2014 | 0.42x | CN¥34.20 Million | CN¥82.19 Million | CN¥34.20 Million | ▼ -42.1% |
| 2013 | 0.72x | CN¥57.91 Million | CN¥80.58 Million | CN¥57.91 Million | ▼ -44.5% |
| 2012 | 1.29x | CN¥45.38 Million | CN¥35.05 Million | CN¥45.38 Million | ▼ -90.7% |
| 2011 | 13.90x | CN¥66.03 Million | CN¥4.75 Million | CN¥66.03 Million | ▲ +1414.0% |
| 2010 | 0.92x | CN¥47.78 Million | CN¥52.03 Million | CN¥47.78 Million | ▲ +686.3% |
| 2009 | 0.12x | CN¥12.33 Million | CN¥105.55 Million | CN¥12.33 Million | — |